Objectives This study aimed to assess the financial burden of out-of-pocket (OOP) payments
to purchase antidiabetic medicines for type 2 patients in Iran. Method The “budget share” …

Background: Diabetes imposes an enormous burden on patients, families, societies, and
healthcare systems. Determining the affordability of medications is an important complicated …

BACKGROUND: Medication costs for antidiabetic drugs have risen significantly in the United
States, causing concerns about the affordability of these essential treatments. OBJECTIVE …

Background Catastrophic health expenditure (CHE) is an indicator used by the World Health
Organization (WHO) to assess equity in households' payments to the health system. In this …

The out-of-pocket payments for prescription medications can impose a financial burden on
patients from low-and middle-incomes and who suffer from chronic diseases. The present …

Background The present study aimed to assess the prevalence and intensity of catastrophic
health-care expenditures (CHE) relating to type 2 diabetes mellitus care and inequality in …

Materials and Methods: All literatures published in the period 2010–2020 were accessed
through two databases: PubMed and Google Scholar. Reference lists of the article were …

Objectives Diabetes is a major public health concern worldwide, particularly in low-income
and middle-income countries (LMICs). Limited data exist on the status of access to diabetes …

Background: Exploring and analyzing the cost of medicines is an important tool for their
management and planning. This study aims to analyze the utilization and costs of parenteral …

Aims To estimate and compare the prescription costs for the management of patients with
diabetes over a period of 20 years in Greece, based on real world data. Methods The …